Manufacturing · Jersey · 1,167 Employees
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure's commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer and ovarian cancer. Headquartered in Jersey, Novocure has U.S. operations in Portsmouth, New Hampshire, Malvern, Pennsylvania and New York City. Additionally, the company has offices in Germany, Switzerland, Japan and Israel.Read More
Headquarters
Phone Number
Website
Revenue
Stock Symbol
Industry
Novocure Inc
Novocure
Novocure Ltd
Novocure GmbH
Novocure?
Phone
Email
$308M
Total Funding Amount
$150M
Most Recent Funding Amount
3
Number of Funding Rounds
Mar 16, 2023
Mar 1, 2023
Mar 1, 2023
Feb 23, 2023
Feb 23, 2023Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure's commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for... Read More
